LOS ANGELES, Aug. 30, 2024 – Investors holding LFCR stocks are now at the helm of a momentous journey. They stand presented with an unprecedented opportunity to spearhead a legal battle against Lifecore Biomedical, Inc. (“Lifecore”) on grounds of securities fraud.
Period of Allegation: October 7, 2020 – March 19, 2024
Lead Plaintiff Cutoff: September 27, 2024
Aspiring to take the lead in the Lifecore lawsuit? Simply provide your contact details at www.glancylaw.com/cases/Lifecore-Biomedical-Inc/. Alternatively, get in touch with Charles H. Linehan, at GPM by dialing 310-201-9150, Toll-Free 888-773-9224, or via email at shareholders@glancylaw.com to comprehend your standing.
Throughout the Class Period, the contentious lawsuit contends that Lifecore’s leadership allegedly failed to disclose to its investors numerous critical aspects. These omissions include the revelation that Lifecore had deficient internal controls over financial reporting, leading to several inaccurate financial statements that needed restating. Moreover, purported remedial actions taken by Lifecore were deemed unsuccessful in addressing these deficiencies adequately. Consequently, Lifecore’s capacity to submit timely reports to the SEC in compliance with NASDAQ listing criteria was severely compromised. As a corollary of these issues, the lawsuit argues that the Company’s financial health and future outlook were significantly overstated, rendering Defendants’ affirmations regarding Lifecore’s business, operations, and prospects misleading or without a substantial foundation throughout the relevant period.
Stay updated with the latest developments by following us on LinkedIn, Twitter, or Facebook.
No immediate action is required to be part of the class action. You may engage your preferred counsel or choose to stay uninvolved and retain your status as an absent member. To gather further insights on this legal pursuit or clarify any dilemmas regarding your involvement in the ongoing class action lawsuit, establish contact with Charles Linehan, Esquire, of GPM at 1925 Century Park East, Suite 2100, Los Angeles, California 90067. Reach out at 310-201-9150, Toll-Free at 888-773-9224, by email at shareholders@glancylaw.com, or visit our website at www.glancylaw.com. For email inquiries, remember to include your current mailing address, contact number, and the number of shares you purchased.
Kindly note that this publication may be deemed as Attorney Advertising in specific jurisdictions based on applicable legislation and ethical norms.
Contact Details:
Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/lfcr-investors-have-opportunity-to-lead-lifecore-biomedical-inc-securities-fraud-lawsuit-302235368.html
SOURCE Glancy Prongay & Murray LLP